Quick Answer
FILANA THERAPEUTICS, INC. reported Total Assets of $118.36 million for the year ending 2025.
- FILANA THERAPEUTICS, INC. showed a decrease of -24.9% in Total Assets from 2024 to 2025.
- This data is from FILANA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $102.59 million | Q3 2011: $100.59 million | Q1 2012: $96.81 million | Q2 2012: $94.44 million | Q3 2012: $93.26 million | Q1 2013: $54.87 million | Q2 2013: $53.20 million | Q3 2013: $51.76 million | Q1 2014: $47.32 million | Q2 2014: $45.39 million | Q3 2014: $43.59 million | Q1 2015: $39.64 million | Q2 2015: $37.76 million | Q3 2015: $35.65 million | Q1 2016: $28.63 million | Q2 2016: $24.94 million | Q3 2016: $22.48 million | Q1 2017: $17.60 million | Q2 2017: $14.27 million | Q3 2017: $12.38 million | Q1 2018: $11.06 million | Q2 2018: $9.83 million | Q3 2018: $20.84 million | Q1 2019: $19.52 million | Q2 2019: $18.81 million | Q3 2019: $18.38 million | Q1 2020: $25.98 million | Q2 2020: $25.50 million | Q3 2020: $25.40 million | Q1 2021: $284.05 million | Q2 2021: $281.31 million | Q3 2021: $274.25 million | Q1 2022: $244.19 million | Q2 2022: $227.38 million | Q3 2022: $207.29 million | Q1 2023: $218.11 million | Q2 2023: $197.25 million | Q3 2023: $172.53 million | Q1 2024: $155.72 million | Q2 2024: $243.57 million | Q3 2024: $223.75 million | Q1 2025: $140.93 million | Q2 2025: $135.38 million | Q3 2025: $129.73 million.
- Over the full 16 years of available data (2010 to 2025), FILANA THERAPEUTICS, INC.'s Total Assets has grown by 19.3%.
- Historical annual values: Fiscal year 2025: $118.36 million | Fiscal year 2024: $157.53 million | Fiscal year 2023: $151.66 million | Fiscal year 2022: $234.83 million | Fiscal year 2021: $266.78 million | Fiscal year 2020: $94.30 million | Fiscal year 2019: $23.49 million | Fiscal year 2018: $20.14 million | Fiscal year 2017: $10.83 million | Fiscal year 2016: $19.30 million | Fiscal year 2015: $31.92 million | Fiscal year 2014: $40.91 million | Fiscal year 2013: $50.10 million | Fiscal year 2012: $56.86 million | Fiscal year 2011: $98.96 million | Fiscal year 2010: $99.20 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: